Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
Open Access
- 28 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Ovarian Research
- Vol. 6 (1), 1-9
- https://doi.org/10.1186/1757-2215-6-42
Abstract
Background: Approximately one third of women diagnosed with ovarian cancer is 70 years or older. Information on the treatment reality of these elderly patients is limited. Methods: 275 patients with primary epithelial ovarian cancer FIGO stage II-IV undergoing cytoreductive surgery and platinum-based chemotherapy were prospectively included in this European multicenter study. Patients <70 and ≥70 years were compared regarding clinicopathological variables and prognosis. Results: Median age was 58 years (18–85); 47 patients (17.1%) were 70 years or older. The postoperative 60-day-mortality rate was 2.1% for elderly and 0.4% for younger patients (p < 0.001). Elderly patients were less likely to receive optimal therapy (no residual disease after surgery and platinum combination chemotherapy) compared to patients <70 years (40.4% vs. 70.1%, p < 0.001) and their outcome was less favorable regarding median PFS (12 vs. 20 months, p = 0.022) and OS (30 vs. 64 months, p < 0.001). However, in multivariate analysis age itself was not a prognostic factor for PFS while the ECOG performance status had prognostic significance in elderly patients. Conclusions: Elderly patients with ovarian cancer are often treated less radically. Their outcome is impaired despite no consistent prognostic effect of age itself. Biological age and functional status should be considered before individualized treatment plans are defined.Keywords
This publication has 26 references indexed in Scilit:
- Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patientsGynecologic Oncology, 2013
- Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patientsGynecologic Oncology, 2012
- Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD ConsortiumCancer Science, 2012
- Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD DataInternational Journal of Gynecologic Cancer, 2012
- Treatment of Elderly Ovarian Cancer Patients in the Context of Controlled Clinical Trials: A Joint Analysis of the AGO Germany ExperienceOnkologie, 2012
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Ovarian cancer in younger vs older women: a population-based analysisBritish Journal of Cancer, 2006
- The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based studyGynecologic Oncology, 2005
- Cancer in older persons: an international issue in an aging worldSeminars in Oncology, 2004